Latest Interviews
Showing 1–15 of 23 transcripts.
Clear all filters- Milken Institute58 min
New Horizons for Accelerating Drug Repurposing
Dr. David Fajgenbaum, Ray, Kristen, Marianne Clancy, Christine Colvis
Hosted by TRiN and Faster Cures, this webinar featured experts from EveryCure, CURE HHT, and NCATS to examine strategies for accelerating the repurposing of existing drugs for rare diseases. Presenters detailed how AI-driven knowledge graphs and patient-led advocacy successfully navigated financial, intellectual property, and regulatory hurdles to secure approvals for conditions like Castleman's disease and Hereditary Hemorrhagic Telangiectasia. The session concluded with a consensus that generating clinical evidence and securing payment pathways are more critical than intellectual property protection for bringing generic therapies to new indications.
- Milken Institute48 min
East Meets West: How Asian Storytelling is Influencing a Global Audience | Asia Summit 2023
Curtis Chin, Randall Park, Guneet Monga, John Penotti, Adele Lim
Speakers at this fragmented panel discussion prioritized global market stability and the need for diverse representation, specifically advocating for more directors of color and indigenous storytelling in the film and television industries. Despite the incoherent nature of the source material, the dialogue identified critical production challenges including high costs, financing difficulties, and the necessity for deeper investment in development. The session concluded with a shared intent to foster authentic narratives and build community structures to support emerging creators before they enter the industry.
- Milken Institute58 min
Antibiotic Resistance and Chronic Disease: Understanding the Challenges and Some Possible Solutions
Amanda Jezek, Jonathan Daniels, David Greenberg, Thomas Heyman, Kathy Talkington, Mark Williams, Tom Heyman
Hosted by Faster Cures in partnership with the Infectious Disease Society of America and other key organizations, this webinar examined the critical market failure hindering new antibiotic development and highlighted its severe impact on cancer, cystic fibrosis, and transplant patients. Panelists presented data showing thousands of annual deaths from antimicrobial resistance while advocating for the "Pasteur Act," a policy designed to de-link financial rewards from sales volume to incentivize the creation of novel drugs for critical pathogens. The event concluded by urging stakeholders to share personal stories and sign a letter to Congress to drive legislative action and secure funding for both antibiotic stewardship and research.
- Milken Institute1h 2m
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
Esther Krofah, Francis Collins, Richard Moscicki, Ellen Sigal, Janet Woodcock
Hosted by Faster Cures, a webinar convened NIH officials and industry leaders to analyze the COVID-19 pandemic's acceleration of biomedical innovation, highlighting achievements such as the ACTIV partnership's master protocols and the RADx initiative's diagnostic scaling. The discussion detailed how the crisis forced a shift toward competitive collaboration, decentralized trials, and the successful achievement of diverse vaccine trial enrollment, while simultaneously exposing critical infrastructure gaps in clinical trial execution and real-world data integration. Panelists concluded with a consensus that emergency-driven reforms must be institutionalized through permanent policy changes and public-private partnerships to sustain preparedness for future health threats.
- Milken Institute1h 17m
Part 1: A Conversation with New Jersey Governor Phil Murphy
Phil Murphy, Edward Greissing, Lynn Goldman, Judith Monroe, David Rhew, Alyssa Rieder
New Jersey Governor Phil Murphy detailed the state's data-driven pandemic response, highlighting the establishment of a massive PPE stockpile, the training of surge healthcare workers, and the creation of a $100 million relief fund for small businesses. Alongside First Lady Tammy Murphy, the administration launched the "Nurture NJ" initiative to address systemic disparities in Black maternal infant mortality while advocating for a strengthened national public health infrastructure and increased federal investment in the CDC and NIH. The broader panel emphasized that future preparedness requires modernizing data infrastructure, closing the digital divide, and implementing a holistic strategy that integrates health equity into all policy decisions to prevent a return to pre-pandemic inequities.
- Milken Institute53 min
Predicting Pandemics: Mobilizing an Active Global Surveillance System
Dan Diamond, Francis deSouza, Margaret Hamburg, John Nkengasong
Despite unprecedented advances in viral sequencing speed during the COVID-19 pandemic, experts identified critical systemic gaps in global pathogen surveillance that relied on serendipitous discovery rather than proactive networks. Highlighting stark disparities between nations like South Korea and underserved regions in Africa, leaders such as Francis D'Souza and Dr. Hamburg outlined a $100 million Genomics Initiative and advocated for a sustainable public-private partnership to fund a "One Health" approach. This collaborative strategy aims to integrate human, animal, and environmental monitoring through modern genomic technologies, ensuring real-time detection of emerging threats while addressing the political and structural barriers that hindered previous pandemic responses.
- Milken Institute1h 2m
Hacking a Pandemic: Healthtech Amid COVID-19
Christian Besler, Dr. Manuel Dayrit, Dr. Joseph Mocanu, Dr. Matthew Wang, Dr. Jeremy Lim, Cesar Purisima
A 2021 health tech roundtable in Manila convened stakeholders to address the Philippines' critical doctor-to-patient ratio and accelerate telemedicine adoption following pandemic-induced behavioral shifts. Drawing on China's integrated ecosystem where platforms like WeDoctor connected 250,000 doctors to 210 million users, the discussion highlighted the urgent need for regulatory reforms to enable insurance reimbursement and data interoperability. With investors like Reach 52 evaluating opportunities and emerging technology enabling remote monitoring of vital signs, the sector aims to transition from crisis-driven emergency measures to a sustainable, preventative healthcare model.
- Milken Institute46 min
Asia Impact: The Future of Work
Lynn Lee, Premlesh Machama, Ahmed Mazhari, Renée McGowan, Anoop Sagoo, Gary Lu
Co-hosted by the Milken Institute and the South China Morning Post, this "Asia Impact" webinar moderated by Lynn Lee featured executives from Microsoft, Mercer, Accenture, and APEC to analyze Asia's post-pandemic trajectory. Panelists detailed how accelerated digital transformation and a critical "Technology Quotient" are reshaping workforce strategies, while also addressing deepening gender disparities and the urgent need for reskilling. The discussion concluded by outlining a hybrid future where leadership demands heightened empathy and flexibility, organizations evolve toward collaborative office hubs, and governments align education with emerging gig-economy realities.
- Milken Institute1h 7m
Technology and the Opening of Trade
Eugene Cornelius, Marianne Jason, Mary Yang, Kevin Smith-Ramos, Fred Hogberg
A panel of experts from the OECD, Canada, Mexico, and the US Ex-Im Bank emphasized that modernizing trade agreements like USMCA and reforming the WTO are critical to helping SMEs overcome financing barriers and digital divides. The discussion highlighted a divergence in national strategies, contrasting the US's fragmented agency approach with Canada's consolidated model while stressing the need for domestic policies to bolster workforce readiness alongside international market access. Ultimately, participants agreed that sustainable global growth requires addressing social inequities and leveraging digital tools to democratize trade participation for smaller enterprises and developing economies.
- Milken Institute1h 1m
Emerging Zoonotic Diseases and Planetary Health: Stopping the Next Pandemic Before It Starts
Melissa Stevens, Simone Friedman, Eric Goode, Mark Smolinski, Gunhild A. Stordalen
Leading experts, policymakers, and investors are mobilizing through the bipartisan "Stop Future Pandemics" bill and a $23 trillion capital initiative to restructure global food systems and halt wildlife trafficking that drives zoonotic disease emergence. This coordinated effort integrates the One Health approach to simultaneously address ecosystem degradation, industrial farming risks, and socioeconomic drivers of spillover by repurposing $700 billion in agricultural subsidies and establishing new ESG disclosure standards. With support from the World Bank, EAT, and over 377 organizations, stakeholders aim to prevent future pandemics by transforming supply chains, funding surveillance technology in resource-limited regions, and ensuring equity for indigenous communities before the next crisis emerges.
- Milken Institute1h 8m
Investing for Impact in Emerging and Frontier Markets
Glenn Yago, Bonnie Glick, Ambassador Gil Haskel, Strive Masiyiwa, Weldon Turner, Malado Kaba, Gil Haskel
Deputy Administrator Bonnie Glick of USAID and Ambassador Gil Haskell of MASHAV launched a strategic partnership to mobilize the $16 trillion U.S. institutional investor community for sustainable infrastructure and digital development in Africa and Asia. Panelists including Strive Masiwa and Weldon Turner emphasized that overcoming a "gap of trust" and standardizing regulatory approval processes are critical to unlocking the $12 trillion in business opportunities outlined by the Sustainable Development Goals. The initiative aims to transition from emergency aid to impact investment by integrating climate-sensitive agriculture, 5G infrastructure, and localized financial solutions to support the projected 2.5 billion people in these regions by 2050.
- Milken Institute55 min
Venture Philanthropy in Action: A Case Study of EB Research Partnership and ProQR
Kristin Schneeman, Michael Hund, Alex Silver, Daniel de Boer, Mark de Souza, Esther Krofa
In a 2020 webinar moderated by Michael Hund of the EB Research Partnership (EBRP), experts Alex Silver, Daniel DeBoer, and Mark D'Souza detailed EBRP's venture philanthropy model, which invests capital in for-profit enterprises to de-risk intellectual property in exchange for financial returns rather than traditional grants. The discussion highlighted a successful collaboration with ProQR Therapeutics that led to the rapid formation of Wings Therapeutics, a structure leveraging equity and milestone-based royalties to accelerate Epidermolysis Bullosa drug development by years. By prioritizing specialized legal counsel and strategic flexibility over standard nonprofit conventions, EBRP aims to catalyze over 30 clinical trials and shift rare disease treatment timelines from years to months while generating competitive financial returns.
- Milken Institute1h 0m
In Search for a Cure: Are We Nearing a Treatment for COVID-19?
Dr Anthony Fauci, Albert Bourla, Esther Krofah, Meg Tirrell
Dr. Anthony Fauci and Pfizer executives outlined the current U.S. pandemic crisis, characterized by rising infections among young demographics and projected second-wave risks in the fall due to premature reopening and asymptomatic spread. While addressing safety protocols like sample pooling for testing and the inclusion of vulnerable populations in trials, Pfizer anticipates initiating Phase 3 trials in July with a potential vaccine rollout by late 2020 or early 2021. Simultaneously, clinical guidelines have been updated to include dexamethasone for severe cases, though experts emphasize that continued public health measures remain essential until herd immunity is achieved.
- Milken Institute1h 4m
The Impact Revolution - Conference Call Series
Glenn Yago, Sir Ronald Cohen, René Karsenti, Julie Monaco, Cynthia Muller
The panel outlines a financial paradigm shift where over $30 trillion in capital now integrates measurable social and environmental impact alongside traditional risk and return metrics. To prevent information asymmetries reminiscent of the 1929 crash, speakers argue for mandatory "impact-weighted accounts" similar to GAAP, citing initiatives by the Harvard Business School and the Network for Greening the Financial System. Furthermore, public-private partnerships are scaling blended finance models through standardized instruments like sustainability-linked bonds, with projections warning that failing to address racial equity could cost the U.S. $70 trillion by 2050.
- Milken Institute58 min
The Long-Term Care Crisis: Exploring Innovative Financing and Delivery Strategies
Nora Super, Jeff Huber, Thomas McInerney, Robert Morse, Bob Morse, Tom McInerney
This session analyzes the critical gap between the aging population's long-term care needs and the current fragmented infrastructure, citing the collapse of the private insurance market and insufficient median assets for the "lost middle." Industry leaders and policymakers discuss pandemic-driven operational shifts, including the acceleration of telehealth and managed care models, alongside workforce initiatives to address staffing shortages. The discussion concludes with urgent recommendations for hybrid public-private financing, expanded social insurance programs, and tax incentives to stabilize the sector before the first baby boomers reach age 80.